首页 | 本学科首页   官方微博 | 高级检索  
文章检索
  按 检索   检索词:      
出版年份:   被引次数:   他引次数: 提示:输入*表示无穷大
  收费全文   100篇
  免费   0篇
综合类   97篇
水路运输   1篇
铁路运输   2篇
  2015年   1篇
  2014年   2篇
  2012年   2篇
  2011年   9篇
  2010年   4篇
  2009年   5篇
  2008年   4篇
  2007年   7篇
  2006年   4篇
  2005年   5篇
  2004年   3篇
  2003年   4篇
  2002年   4篇
  2001年   3篇
  2000年   11篇
  1999年   7篇
  1998年   4篇
  1997年   11篇
  1996年   4篇
  1995年   2篇
  1994年   1篇
  1987年   1篇
  1986年   1篇
  1984年   1篇
排序方式: 共有100条查询结果,搜索用时 15 毫秒
51.
The tyrosine kinase receptor C-erbB-2 (alsocalled HER-2/neu) is a member of the epidermalgrowth factor receptor (EGFR ) family. Memberproteins of this fami1y are membrane proteins andeach of which contains an intracellular domain, atransmembrane domain and an intracellular regionwith intrinsic tyrosine kinase activity. C--erbB-2gene plsay an important role in the development ofcancer. Overexpression of C-erbB-2 can not onlyenhance the ability of the growth and metastaticpotential in cance…  相似文献   
52.
53.
Objective To estimate the relative risk for lung cancer associated with genetic polymorphism of T6235C mutation in 3' non-coding region (Msp Ⅰ) of cytochrome P450 1A1 (CYP1A1) and glntathione S-transferase M1 (GSTM1) in the Mongolian population in Inner Mongolian Region of China. Methods Polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP) and multiplex PCR methods were used to analyze blood samples obtained from 263 case subjects and 263 control subjects to determine their genotypes for CYP1A1 and GSTM1.Control subjects were matched with case subjects by ethnic background, age and gender. Results The frequencies of the variant CYP1A1 genotypes (CYP1A1C) and GSTM1-null in lung cancer groups were higher than those in control groups (38.4% vs. 28. 5% and 57.8% vs. 48.0%). The individuals who corried with CYP1A1C genotype had a significantly higher risk of lung cancer (OR=1.56, 95% CI=1.08 to 2.25, P=0.016) than those who carried with non-variation CYP1A1 genotype. The ones who carried with GSTM1-null genotype also had a significantly higher risk of lung cancer (OR=1.49, 95% CI=1.06 to 2.10, P=0.023) than these who carried with GSTM1-present genotype.When combination of polymorphisms of CYP1A1 and GSTM1 genotypes was analyzed, the risk of lung cancer for combination of CYP1A1C and GSTM1-null genotypes was increased significantly (OR=2.084, 95e CI=1.27 to 3.42, P=0.003). Susceptibility to lung cancer was related to smoking (OR=2.10, 95% CI=1.48 to 2.98, P=0.000). Considering smoking status, the risk of lung cancer for combination of smoking and CYP1A1C genotype was remarkably increased (OR=2.76, 950/0 CI=1.74 to 4. 37, P=0.000). It was the same case with combination of smoking and GSTM1-null genotype (OR=4. 38, 95% CI=2.35 to 8.15, P=0.000). Conclusion The polymorphisms of CYP1A1C genotype and GSTM1-null are the risk factors of lung cancer in the Mongolian population in Inner Mongolia Region of China. Smoking is also related to susceptibility to lung cancer. There may be a synergetic interaction between CYP1A1C and GSTM1-null in the elevated susceptibility of lung cancer. Smoking may have a synergetic interaction with CYP1A1C and GSTM1-null in the elevated susceptibility of lung cancer.  相似文献   
54.
Itis increasingly apparentthatthe main reasonforthe failure of anti- tumor immune response is theinactivation of TIL (Tumor Infiltrating Lympho-cyte,TIL) .The activation of immunocompetentcells is largely dependent on their local microenvi-ronment.Since the tumor local microenvironmentisthe frontier where host immunocompetent cells in-teract with the tumor cells directly,analyzing thetumor local microenvironment,especially compar-ing it to anti- inflammatory immune microenviron-ment,is very…  相似文献   
55.
Recently,the mortality of lung cancerincreasesin many areas and countries,and lung cancer is be-coming the major disease in malignant tumour re-search.Baoji city was found to be one of the citieswith high lung cancer incidence in China in early1 970 s[1] . Thereafter,intervention measures havebeen adopted,such as establishing the Environmen-tal Monitoring Station in Baoji to control the pollu-tion of land,water and air,a number of workshopsand propaganda in cancer prevention,smoking- con-tro…  相似文献   
56.
目的 探讨 Bcl- 2和 Bax蛋白表达与非小细胞肺癌 (NSCLC)临床病理特征的关系。方法 应用免疫组化 SP法检测了 30例正常肺组织和 61例 NSCLC中 Bcl- 2和 Bax蛋白的表达。结果  NSCLC组织中 Bcl- 2蛋白表达率 (57.38% )显著高于正常肺组织 (1 3.33% ) (P <0 .0 1 ) ,而NSCLC组织中 Bax蛋白表达率 (45.90 % )显著低于正常肺组织 (80 .0 0 % ) (P <0 .0 1 ) ,鳞癌和腺癌中 Bcl- 2和 Bax蛋白表达率均无显著差异 (P >0 .0 5) ,Bcl- 2蛋白表达率与 NSCLC病理分级及淋巴转移潜能呈正相关 (P <0 .0 5) ,与 P- TNM分期无关 (P >0 .0 5) ,Bax蛋白表达率与NSCLC病理分级、P- TNM分期及淋巴转移潜能呈负相关 (P <0 .0 1~ 0 .0 0 5) ,Bcl- 2和 Bax蛋白在 NSCL C中的表达呈负相关 (χ2 =9.93,P <0 .0 0 5)。结论  Bcl- 2和 Bax蛋白相互抑制 ,均与 NSCLC发生、发展有关 ,可作为反映 NSCLC生物学行为的指标  相似文献   
57.
目的观察榄香烯乳联合化疗对小鼠Lewis肺癌的抑瘤作用,探讨其抑瘤作用机制。方法 32只C57BL小鼠右腋下接种Lewis肺癌细胞成瘤,随机分为4组:肺癌模型组、化疗组(足叶乙甙3mg/kg+顺铂3mg/kg,6mg/kg)、榄香烯乳组(100mg/kg)、榄香烯乳+化疗组(106mg/kg),每组8只。连续给药7d后,观察脾脏及胸腺指数变化,测定抑瘤率及抑制转移率,并进行组织病理学检测以及透明质酸酶(HAase)和组织金属蛋白酶抑制剂-1(TIMP-1)蛋白表达测定。结果与单纯化疗组比较,榄香烯乳联合化疗组抑瘤率及抑制转移率明显升高,肺癌小鼠脾脏指数及胸腺指数显著增加,瘤组织细胞形态结构得到改善,TIMP-1蛋白阳性表达率降低明显。结论榄香烯乳联合化疗对小鼠Lewis肺癌的抑瘤作用明显,其作用机制与增强细胞外基质及免疫调节有关。  相似文献   
58.
采用混合单克隆抗体金标免疫斑点法对46例肺癌患者放疗前后及30例肺良性病和20例正常对照血清的肺癌相关抗原(LCA)进行检测。结果表明:肺癌患者放疗前LCA的阳性率为97.83%,明显高于正常对照(0%)及肺良性病(13.33%)(P<0.005);放疗后LCA的阳性率为82.61%,较放疗前明显下降(P<0.05),LCA的阳性率在不同病理类型、临床分期及近期疗效间无显著性差异(P>0.05)。  相似文献   
59.
为探讨nm23、c-erbB-2基因在评估肺癌生物学行为及预后中的作用,应用免疫组化ABC法检测了41例肺癌及30例癌分组织中nm23及c-erbB-2的表达。结果表明癌组织中nm23kc-erbB-2表达率显著高于癌旁组织(P<0.001);两者相关性极强(X2=6.62,P<0.02),且均与癌病理分级、TNM分期及肺门和(或)纵隔淋巴结转移(简称分级、分期及转移)呈正相关(P<0.001、0.01或0.05)。提示nm23及c-erbB-2基因表达可作为肺癌诊断及预后和生物学行为评估的指标。  相似文献   
60.
GinsenosideRg3isthefirstnewChineseanti cancerdrugwithmonomestructure .Accordingtostudiesonitspharmacodynamics ,thedrugishelpfulininhibitingthe proliferationandneovasculariza tionofendothelialcellsoftumorvessels .Ifnonewvesselsarefoundinthetissues,itisdifficultfortu morcellstodiffuseortransfer.EntrustedbytheAssessmentCenterofStateDrugAdministration(SDA) ,weundertooktheexperimenttofurthertestthesafetyandeffectivenessofthedrug .Theexperimentplanwasverifiedbytheexpertgroup .MATERIALSANDM…  相似文献   
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号